CENTO, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 2.767
NA - Nord America 1.683
AS - Asia 1.284
SA - Sud America 179
AF - Africa 77
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.000
Nazione #
US - Stati Uniti d'America 1.627
DE - Germania 1.084
GB - Regno Unito 712
IT - Italia 457
CN - Cina 456
SG - Singapore 456
BR - Brasile 140
HK - Hong Kong 110
SE - Svezia 89
RU - Federazione Russa 82
IN - India 71
FR - Francia 62
IE - Irlanda 56
FI - Finlandia 49
NL - Olanda 41
TR - Turchia 38
VN - Vietnam 36
CI - Costa d'Avorio 35
CA - Canada 34
ID - Indonesia 32
DK - Danimarca 29
ES - Italia 22
CH - Svizzera 20
MX - Messico 17
JP - Giappone 14
ZA - Sudafrica 14
AR - Argentina 11
AT - Austria 11
PH - Filippine 10
AU - Australia 9
BE - Belgio 9
CO - Colombia 9
CZ - Repubblica Ceca 8
KR - Corea 8
PL - Polonia 8
TW - Taiwan 8
UA - Ucraina 8
EC - Ecuador 7
ET - Etiopia 6
SC - Seychelles 6
IR - Iran 5
MA - Marocco 5
PK - Pakistan 5
RS - Serbia 5
TH - Thailandia 5
IQ - Iraq 4
KE - Kenya 4
PE - Perù 4
RO - Romania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
IL - Israele 3
KG - Kirghizistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
JM - Giamaica 2
LV - Lettonia 2
MY - Malesia 2
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GR - Grecia 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.000
Città #
Frankfurt am Main 1.004
Southend 660
Singapore 264
Ashburn 220
Chandler 171
Fairfield 161
Milan 139
Hong Kong 96
Beijing 70
Seattle 63
Wilmington 58
Houston 57
Woodbridge 55
San Jose 54
Dallas 50
Princeton 50
Dublin 49
Cambridge 47
Santa Clara 46
Helsinki 39
Los Angeles 38
Abidjan 35
Redwood City 35
Council Bluffs 34
Ann Arbor 28
Jakarta 27
Rome 27
Istanbul 26
Dearborn 25
Nanjing 25
Munich 23
New York 23
Guangzhou 20
Bengaluru 19
Shanghai 19
Jinan 18
Phoenix 18
Columbus 16
Des Moines 16
São Paulo 16
Toronto 16
The Dalles 15
Boardman 14
Cangzhou 14
Changsha 13
Kent 13
Buffalo 12
San Diego 11
Central District 10
Moscow 10
Paris 10
Tokyo 10
Berlin 9
Wuhan 9
Zurich 9
Nuremberg 8
Shenyang 8
Zhengzhou 8
Brussels 7
Düsseldorf 7
Ho Chi Minh City 7
Mumbai 7
Ottawa 7
Shenzhen 7
Turku 7
Bexley 6
Chicago 6
Florence 6
Fremont 6
Hangzhou 6
Hanoi 6
Johannesburg 6
London 6
Mahé 6
Margão 6
Nanchang 6
Naples 6
Porto Alegre 6
Turin 6
Brescia 5
Bronx 5
Catania 5
Hebei 5
Hyderabad 5
Rho 5
Rio de Janeiro 5
Seoul 5
Torino 5
Ankara 4
Delhi 4
Falls Church 4
Ferrara 4
Haikou 4
Jiaxing 4
Lanzhou 4
Lohmar 4
Montreal 4
Orem 4
Quanzhou 4
Venezia 4
Totale 4.266
Nome #
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy 553
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients 425
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients 405
In vivo acquisition and risk of inter-species spread of blaKPC-3-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract 363
Real life experiences in HCV management in 2018 350
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 304
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens 297
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy 263
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy 254
Rapid Detection and Quantification of Mycobacterium tuberculosis DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study 242
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district 230
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 220
Optimal cure rate by personalized HCV regimens in real-life : a proof-of-concept study 212
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients : a diagnostic test accuracy study 212
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 210
Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine 186
Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients 174
Thymic-and bone marrow-cellular reservoirs harbor phylogenetically distinct HIV strains and different resistance profiles 163
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 158
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 156
Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe—short- And long-term Immune reSponSe evAluatioN in health Care workErs 139
Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality 136
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 130
Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens : A real-life experience 101
Treatment of Hepatitis C virus infection in Italy : a consensus report from an expert panel 101
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 93
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures : what are the chances for second-line regimens? 89
Totale 6.166
Categoria #
all - tutte 15.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021540 0 0 0 0 0 0 176 124 63 86 44 47
2021/2022604 58 50 56 39 37 47 31 42 71 56 32 85
2022/2023560 73 71 60 47 55 85 11 38 70 10 35 5
2023/20241.007 13 32 20 34 79 51 158 133 62 131 150 144
2024/20251.170 134 142 107 140 79 53 29 79 49 77 90 191
2025/20261.009 176 98 180 183 190 125 57 0 0 0 0 0
Totale 6.166